Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance.

MLA

Stenton, Sarah L., et al. “Expanding the Clinical and Genetic Spectrum of FDXR Deficiency by Functional Validation of Variants of Uncertain Significance.” Human Mutation, vol. 42, no. 3, Mar. 2021, pp. 310–19. EBSCOhost, https://doi.org/10.1002/humu.24160.

APA

Stenton, S. L., Piekutowska-Abramczuk, D., Kulterer, L., Kopajtich, R., Claeys, K. G., Ciara, E., Eisen, J., Płoski, R., Pronicka, E., Malczyk, K., Wagner, M., Wortmann, S. B., & Prokisch, H. (2021). Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance. Human Mutation, 42(3), 310–319. https://doi.org/10.1002/humu.24160

Chicago

Stenton, Sarah L, Dorota Piekutowska-Abramczuk, Lea Kulterer, Robert Kopajtich, Kristl G Claeys, Elżbieta Ciara, Johannes Eisen, et al. 2021. “Expanding the Clinical and Genetic Spectrum of FDXR Deficiency by Functional Validation of Variants of Uncertain Significance.” Human Mutation 42 (3): 310–19. doi:10.1002/humu.24160.